MaRS is pleased to announce the Faurecia Biosensing Safety Challenge, a new competition set to award one grand-prize winner $25,000 USD.
Created by Faurecia (a $20-billion global tech company) the Biosensing Safety Challenge asks Canadian ventures and institutions to provide novel tech — sensors, software, and much more — for detecting at least one sign, symptom or biomarker of a stroke, heart attack or diabetic event of a vehicle passenger.
Ideal solutions for this challenge can come from various sectors and disciplines: voice recognition software to identify slurred speech; a sensor which can detect breathing or heart rate; and so on. An info sheet with additional signs, symptoms, and biomarkers can be found here.
- The top three finalists will present to Faurecia in a pitch session at Health Innovation Week, Canada’s largest gathering of health startups, investors, academics and more
- One grand winner will be awarded $25,000 USD, as well as the chance to collaborate on future projects with Faurecia
Challenge deadline: Feb. 28, 2020 at 11:59 p.m. EST